Millions of patients carry permanent cardiac leads. When those leads fail or get infected, removing them is one of the most dangerous procedures in cardiology. RetractCor is designing leads built for safe extraction from day one.
Every year, tens of thousands of patients need their cardiac leads removed due to infection, device failure, or venous occlusion. The procedure hasn't fundamentally changed in decades.
Within months of implantation, scar tissue (fibrosis) encases the lead body, bonding it to vessel walls and cardiac tissue. After 1-2 years, simple traction almost never works. The longer the dwell time, the more dangerous extraction becomes.
Removing encased leads risks cardiac perforation, vascular tears, superior vena cava injury, and hemodynamic collapse. Even in the best centers, major complications occur in 1.4-1.6% of cases. The in-hospital mortality rate is 0.28%.
When extraction is too risky, leads are abandoned in situ. An estimated 17-25% of patients with CIEDs have at least one abandoned lead. These cause venous obstruction, tricuspid regurgitation, and complicate future procedures.
Lead extraction requires specialized centers, surgical teams, and OR standby. Average procedure cost is $35,000-$50,000. The global lead extraction market approaches $1 billion annually, all spent managing a preventable design problem.
Published clinical data from large registries and multicenter trials paint a clear picture: lead extraction remains high-risk, and the problem is growing.
Overall procedure-related death rate from the ELECTRa registry, the largest prospective lead extraction study (3,510 patients across 73 centers).
Rate of life-threatening complications including cardiac perforation, hemothorax, and vascular tear. Requires emergency intervention in most cases.
Even with powered extraction tools (laser sheaths, rotational devices), 10-15% of extractions fail to fully remove all lead material from the patient.
Lead dwell time is the strongest predictor of extraction difficulty. Every year a lead remains implanted, fibrotic adhesions intensify, making extraction more dangerous and less likely to succeed.
Current extraction technology (laser sheaths, mechanical dilator sheaths, and rotational tools) addresses fibrosis after it forms. RetractCor's approach prevents the adhesion cascade from the start.
Current cardiac leads are engineered to stay in forever. But patients outlive their devices, infections happen, and technology improves. RetractCor starts with a different premise: every lead should be safely removable.
Instead of building better extraction tools for leads that resist removal, we're building leads that don't resist removal in the first place.
Cardiac leads are a massive, growing market. But the industry has optimized for implantation, not the full device lifecycle.
The global market for implantable cardiac leads, growing at 5.2% CAGR driven by aging populations and expanding CRM indications. Every lead implanted today will eventually need management or removal.
Spent annually on tools, procedures, and specialized centers dedicated to removing leads that weren't designed to come out. A market that exists only because of a design problem.
Annual patients receiving multi-chamber CRT or ICD leads that cannot be replaced by leadless technology. These patients need leads, and those leads need to be extractable.
Estimated percentage of implanted leads that will require intervention (extraction, revision, or abandonment) within the device's functional lifetime, based on 15-year follow-up data.
RetractCor was founded on a simple observation: if we know leads need to come out, why aren't we designing them for removal?
The cardiac rhythm management industry has spent decades optimizing lead fixation, conductor durability, and sensing performance. These are solved problems. What remains unsolved is the other end of the lifecycle: when the lead needs to be removed, upgraded, or replaced.
We're assembling a team of cardiac device engineers, electrophysiologists, and materials scientists focused exclusively on this problem. Our goal is to make lead extraction as routine as lead implantation.
Whether you're a cardiologist, device engineer, researcher, or potential partner, we'd like to hear from you. We're actively building our clinical advisory network and engineering team.
Leadless pacemakers solve part of the problem, but millions of patients still need traditional leads for complex cardiac therapy. RetractCor is building the leads those patients deserve.
Join the Mission →